Sanofi Genzyme News |

Featured Press Releases

July 18, 2018
Sanofi and REVOLUTION Medicines Launch Global Partnership to Develop Potential First-in-Class Targeted Treatments for Multiple Cancers
Sanofi and REVOLUTION Medicines, Inc. today announced an exclusive worldwide partnership to develop and commercialize targeted therapies, based on the biology of the cellular enzyme SHP2, for patients with non-small lung cancer and other types of cancer carrying certain mutations. This...
June 4, 2018
New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma
The New England Journal of Medicine (NEJM) today published pivotal data from two trials evaluating cemiplimab in advanced cutaneous squamous cell carcinoma (CSCC). The results were also presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. Advanced CSCC, the deadliest...
May 21, 2018
New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma
PARIS and TARRYTOWN, NY – May 21, 2018 –The New England Journal of Medicine (NEJM) today published detailed results from two Phase 3 trials for the investigational use of Dupixent® (dupilumab) in moderate-to-severe asthma. The results showed that Dupixent significantly reduced the risk...
May 16, 2018
First positive clinical data for cemiplimab in advanced non-small cell lung cancer to be shared at ASCO
The first positive Phase 1 clinical data assessing cemiplimab as a potiential treatment for advanced non-small cell lung cancer (NSCLC) will be shared at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. Cemiplimab is an investigational human monoclonal antibody targeting the immune...

Leadership

Bill Sibold
Executive Vice President and Head of Sanofi Genzyme
Bill joined Sanofi Genzyme in 2011 as Senior Vice President and Head of Multiple Sclerosis, and oversaw the successful launches of its two MS treatments. As Head of Sanofi Genzyme, he leads the business’s efforts to maintain its leadership in rare diseases while continuing to grow in multiple sclerosis, oncology and immunology. More...

Tweets

Christine is a summer intern working in Global Medical Affairs. She is looking forward to her senior year at… https://t.co/Rh9YdpFsKl-20 hours 46 min ago

Richell is a summer intern working with our marketing teams. She is interested in pursuing a career in business an… https://t.co/gPDsosaHjd-1 day 19 hours ago

The summer interns are busy getting to know our business, like Elizabeth who is working in our #Humanitarian progra… https://t.co/3e9R0l3J4G-2 days 20 hours ago

RT @MPSSociety: Did you create a painting at the art booth in the exhibitor hall? If so, post it and tag us! #mps2018 https://t.co/qYqFKnUaqL-3 days 17 hours ago

Our team is excited to take part in this event and sponsor the great work @UpliftingAth does to promote… https://t.co/xp3Y1CVjdX-3 days 20 hours ago

Search Newsroom

Featured Press Releases

Featured Videos

Leadership

Media Resources

Tweets

Social Media